Transforming drug delivery platform for bone cancer
Our Technology
We incorporate approved tumor killing molecules with high accretion to nano and micro particles of the bone minerals i.e., Hydroxyapatite (HA). In addition, a systemic loading of a specific drug will seek, bind, and exert a local biological effect. This increases the efficacy of targeted drug delivery without causing side-effects in other tissues.